focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Foods Regulatory News (ABF)

Share Price Information for AB Foods (ABF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,738.00
Bid: 2,741.00
Ask: 2,742.00
Change: 27.00 (1.00%)
Spread: 1.00 (0.036%)
Open: 2,713.00
High: 2,747.00
Low: 2,713.00
Prev. Close: 2,711.00
ABF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase Programme

9 Nov 2022 07:00

RNS Number : 8069F
Associated British Foods PLC
09 November 2022
 

Associated British Foods plc

9 November 2022

 

Associated British Foods plc share repurchase programme

 

Further to its announcement on 8 November 2022, Associated British Foods plc (the "Company") announces that it is to commence the first tranche of its up to £500 million share buyback programme (the "Programme").

 

The first tranche of the Programme will be in the sum of up to £250 million and will commence today, 9 November 2022, and it is anticipated to end on or before 28 April 2023 (the "Engagement Period").

 

To execute the first tranche of this buyback, the Company has entered into an irrevocable and non-discretionary arrangement with Barclays Capital Securities Limited ("Barclays") to buy back up to £250 million of its ordinary shares (the "Engagement").

 

Under this arrangement, Barclays will act as principal and will make decisions independently from the Company under the Engagement. Barclays will carry out the arrangement through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. Purchases may continue during any closed period to which the Company is subject during the Engagement Period.

 

The sole purpose of the share buyback is to reduce the capital of the Company. All ordinary shares repurchased as part of this arrangement will be cancelled.

 

Share purchases will take place in open market transactions and be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and may be made from time to time depending on market conditions, share price, trading volume and other factors.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be effected within certain pre-set parameters and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase ordinary shares granted by its shareholders (at the AGM in 2021, shareholders gave the Company authority to purchase a maximum of 79,167,418 ordinary shares), the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018) and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

The Company intends to enter into arrangements to commence a second tranche of the Programme in the sum of £250 million in due course.

 

 

Further enquiries:

+44 (0)20 7399 6545

John Bason, Finance Director

Chris Barrie, Corporate Affairs Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKLBBLFLEFBB
Date   Source Headline
31st Dec 201911:00 amRNSDirector Declaration
10th Dec 20194:29 pmRNSDirector/PDMR Shareholding
6th Dec 20193:45 pmRNSResult of AGM
6th Dec 20197:00 amRNSAGM Trading Statement
27th Nov 20193:14 pmRNSDirector/PDMR Shareholding
5th Nov 201910:22 amRNSAnnual Financial Report
5th Nov 20197:05 amRNSFinal dividend for year ended 14 September 2019
5th Nov 20197:00 amRNSAnnual Results
1st Oct 201910:38 amRNSDirector Declaration
11th Sep 20195:04 pmRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSPre Close Period Trading Update
3rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
2nd Aug 20193:51 pmRNSDirector/PDMR Shareholding
25th Jul 20195:47 pmRNSDirector Declaration
12th Jul 20199:06 amRNSDirector/PDMR Shareholding
12th Jul 20199:01 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update
24th Apr 20197:05 amRNSInterim dividend
24th Apr 20197:00 amRNS2019 Interim Results Announcement
3rd Apr 201910:44 amRNSDirector Declaration
1st Mar 20195:41 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSPre Close Period Trading Update
17th Jan 20197:00 amRNSTrading Update
16th Jan 20199:00 amRNSDirector/PDMR Shareholding
7th Dec 20183:07 pmRNSResult of AGM
7th Dec 20187:00 amRNSAGM Trading Statement
27th Nov 20183:52 pmRNSDirector/PDMR Shareholdings
21st Nov 20186:34 pmRNSDirector/PDMR Shareholding
8th Nov 201810:30 amRNSAnnual Report and Accounts 2018
6th Nov 20187:01 amRNSFinal dividend for the year
6th Nov 20187:00 amRNSAnnual Results
22nd Oct 201811:08 amRNSHoldings in Company
10th Sep 20187:00 amRNSPre Close Period Trading Update
5th Sep 20184:22 pmRNSDirectorate Change
23rd Jul 20183:59 pmRNSDirector / PDMR announcement for John Bason
6th Jul 20184:55 pmRNSDirector/PDMR Shareholding
5th Jul 20187:00 amRNSTrading Update
30th May 20189:39 amRNSDirector/PDMR Shareholding
18th Apr 20183:28 pmRNSDirector/PDMR Shareholding
17th Apr 20187:05 amRNSInterim Dividend
17th Apr 20187:00 amRNSInterim Results announcement
27th Feb 20184:22 pmRNSDirector/PDMR Shareholding
26th Feb 20187:00 amRNSTrading Statement
22nd Feb 201810:00 amRNSDirectorate Change
18th Jan 20187:00 amRNSTrading Update
15th Jan 20185:04 pmRNSDirector/PDMR Shareholding
3rd Jan 201810:57 amRNSDirector Declaration
8th Dec 20173:46 pmRNSResult of AGM
8th Dec 201711:03 amRNSChairman's Address to AGM
28th Nov 20172:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.